Drug Trial Radar · NCT06619236
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
584
Actual
Start
Feb 7, 2025
Primary completion
Aug 18, 2026
Study completion Oct 2027
Sponsor
- Lead sponsor
- GenmabIndustry
- Sponsor type
- Industry
- First posted
- Oct 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase 3 study will be conducted in different countries all over the world. The purpose of this study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already approved and used for platinum-resistant ovarian cancer. Treatment in this study could be Rina-S or it could be 1 of 4 indicated chemotherapy agents that are considered standard medical care. There is an equal (50:50) chance of getting Rina-S or an approved chemotherapy agent as treatment in this study. No one will know what treatment they are assigned to until the first dose. All participants will receive active drug; no one will be given placebo.
Conditions
- Platinum-resistant Ovarian Cancer
Interventions
Rina-SDrug
Intravenous (IV) infusion
PaclitaxelDrug
IV infusion
TopotecanDrug
IV infusion
Pegylated liposomal doxorubicin (PLD)Drug
IV infusion
GemcitabineDrug
IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS)Time frame: Up to approximately 1.5 years
Locations
177 sites in 18 countries. Site status is shown where the registry gives one.
Alaska Women's Cancer Care
Anchorage, Alaska
Arizona Center for Cancer Care (ACCC) - Biltmore
Scottsdale, Arizona
University of Arizona Cancer Center - Research and Administration at Main Campus
Tucson, Arizona
Providence Saint Joseph Medical Center - Roy and Patricia Disney Family Cancer Center
Burbank, California
University of California San Diego Moores Cancer Center
La Jolla, California
USCF Mission Bay
San Francisco, California
Kaiser Permanente - Vallejo Medical Center
Vallejo, California
UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center
Aurora, Colorado
Hartford Hospital
Hartford, Connecticut
Yale School of Medicine
New Haven, Connecticut
Norwalk Hospital
Norwalk, Connecticut
SCRI - Florida Cancer Specialists - South Region Research Office
Fort Myers, Florida
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida
Orlando Health Cancer Institute - Downtown Orlando
Orlando, Florida
Sarasota Memorial Hospital
Sarasota, Florida
SCRI - Florida Cancer Specialists - West Palm Beach
West Palm Beach, Florida
Winship Cancer Institute of Emory University
Atlanta, Georgia
Northside Hospital Atlanta
Atlanta, Georgia
Augusta University Georgia Cancer Center
Augusta, Georgia
Kapi'olani Medical Center for Women and Children
Honolulu, Hawaii
Northwest Cancer Center - Dyer
Dyer, Indiana
University of Kansas Cancer Center
Kansas City, Kansas
HCA Midwest Health
Overland Park, Kansas
St. Elizabeth Healthcare - Edgewood
Edgewood, Kentucky
Baptist Health Lexington
Lexington, Kentucky
Louisiana State University Health Sciences Center (LSU Health) - New Orleans
New Orleans, Louisiana
Trials365, LLC (Gynecologic Oncology Associates-Shreveport)
Shreveport, Louisiana
Maine Medical Center Cancer Institute- Scarborough
Scarborough, Maine
Holy Cross Health - Holy Cross Hospital
Silver Spring, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan
Corewell Health (Spectrum Health)
Grand Rapids, Michigan
Saint Joseph Mercy Ann Arbor Hospital
Ypsilanti, Michigan
University of Nebraska Medical Center
Omaha, Nebraska
Center of Hope
Reno, Nevada
Holy Name Medical Center
Teaneck, New Jersey
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico
Roswell Park Comprehensive Cancer Center
Buffalo, New York
Perlmutter Cancer Center - 38th Street
New York, New York
Showing 40 of 177 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.